Researchers and clinicians with an interest in insulin resistance, diabetes, and cardiovascular disease are invited to join the EGIR Study Group.
EGIR membership provides access to scientific meetings and webinars, collaborative research opportunities, and EGIR-related publications and study initiatives.
Join EGIR to contribute to and engage with a European network dedicated to advancing research in insulin resistance. Please send your request to the following email: lucrecia.mota@med.unipi.it
1992 - Prague
The first EGIR meeting is held, focusing on pre-diabetes, insulin resistance, and metabolic syndrome.
Founding participants include Stefano Del Prato, Johan Eriksson, Eveline Eschwège, Ele Ferrannini, Annick Fontbonne, Leif Groop, Rury Holman, Hans Janka, Markku Laakso, Hans Lithell, André Scheen, Marja-Riitta Taskinen, Robert Turner, and Ivana Zavaroni.
1993 - Château de Maffliers, France
Second EGIR meeting organized by Annick Fontbonne, Leif Groop, and Christophe Pasik, sponsored by Lipha.
Topics include:
Predictors of NIDDM
34 participants | 16 scientific abstracts
1995 - European Research Collaboration
Ele Ferrannini proposes combining hyperinsulinaemic–euglycaemic clamp data from multiple European centers.
This initiative results in a landmark publication in the Journal of Clinical Investigation, establishing EGIR as a leading research network.
2001 - Launch of the EGIR-RISC Study
The project Relationship between Insulin Sensitivity and Cardiovascular Disease (RISC) receives funding from the European Commission, with additional support from AstraZeneca.
21 European centers | Over 1,000 healthy volunteers recruited.
2001 - Present - Ongoing Scientific Impact
The EGIR-RISC cohort continues long-term follow-up.
Numerous influential publications contribute to understanding insulin resistance and cardiovascular risk.
Since 1992 - Annual EGIR Meetings
EGIR meetings are held annually, expanding scientific discussions beyond insulin resistance to broader metabolic and cardiovascular research.